The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hirudin-Global Market Insights and Sales Trends 2025
Synopsis
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
The global Hirudin market size is expected to reach US$ 4934.7 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Hirudin in various end use industries. The expanding demands from the Thrombosis Disease, Tumor Disease and Others,, are propelling Hirudin market. Natural Hirudin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Hirudin segment is estimated at % CAGR for the next seven-year period.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hirudin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hirudin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hirudin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hirudin covered in this report include The Medicines Company, Keyken, Minapharm, Abbott, SALUBRIS, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, DUOPUTAI and Pentapharm, etc.
The global Hirudin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
Global Hirudin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hirudin market, Segment by Type:
Natural Hirudin
Recombinant Hirudin
Global Hirudin market, by Application
Thrombosis Disease
Tumor Disease
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hirudin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
The global Hirudin market size is expected to reach US$ 4934.7 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Hirudin in various end use industries. The expanding demands from the Thrombosis Disease, Tumor Disease and Others,, are propelling Hirudin market. Natural Hirudin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Hirudin segment is estimated at % CAGR for the next seven-year period.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hirudin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hirudin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hirudin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hirudin covered in this report include The Medicines Company, Keyken, Minapharm, Abbott, SALUBRIS, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, DUOPUTAI and Pentapharm, etc.
The global Hirudin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
Global Hirudin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hirudin market, Segment by Type:
Natural Hirudin
Recombinant Hirudin
Global Hirudin market, by Application
Thrombosis Disease
Tumor Disease
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hirudin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hirudin Market Overview
1.1 Hirudin Product Overview
1.2 Hirudin Market Segment by Type
1.2.1 Natural Hirudin
1.2.2 Recombinant Hirudin
1.3 Global Hirudin Market Size by Type
1.3.1 Global Hirudin Market Size Overview by Type (2018-2029)
1.3.2 Global Hirudin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hirudin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hirudin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hirudin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hirudin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hirudin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hirudin Sales Breakdown by Type (2018-2023)
2 Global Hirudin Market Competition by Company
2.1 Global Top Players by Hirudin Sales (2018-2023)
2.2 Global Top Players by Hirudin Revenue (2018-2023)
2.3 Global Top Players by Hirudin Price (2018-2023)
2.4 Global Top Manufacturers Hirudin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hirudin Market Competitive Situation and Trends
2.5.1 Hirudin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hirudin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hirudin as of 2022)
2.7 Date of Key Manufacturers Enter into Hirudin Market
2.8 Key Manufacturers Hirudin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hirudin Status and Outlook by Region
3.1 Global Hirudin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hirudin Historic Market Size by Region
3.2.1 Global Hirudin Sales in Volume by Region (2018-2023)
3.2.2 Global Hirudin Sales in Value by Region (2018-2023)
3.2.3 Global Hirudin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hirudin Forecasted Market Size by Region
3.3.1 Global Hirudin Sales in Volume by Region (2024-2029)
3.3.2 Global Hirudin Sales in Value by Region (2024-2029)
3.3.3 Global Hirudin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hirudin by Application
4.1 Hirudin Market Segment by Application
4.1.1 Thrombosis Disease
4.1.2 Tumor Disease
4.1.3 Others
4.2 Global Hirudin Market Size by Application
4.2.1 Global Hirudin Market Size Overview by Application (2018-2029)
4.2.2 Global Hirudin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hirudin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hirudin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hirudin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hirudin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hirudin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hirudin Sales Breakdown by Application (2018-2023)
5 North America Hirudin by Country
5.1 North America Hirudin Historic Market Size by Country
5.1.1 North America Hirudin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hirudin Sales in Volume by Country (2018-2023)
5.1.3 North America Hirudin Sales in Value by Country (2018-2023)
5.2 North America Hirudin Forecasted Market Size by Country
5.2.1 North America Hirudin Sales in Volume by Country (2024-2029)
5.2.2 North America Hirudin Sales in Value by Country (2024-2029)
6 Europe Hirudin by Country
6.1 Europe Hirudin Historic Market Size by Country
6.1.1 Europe Hirudin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hirudin Sales in Volume by Country (2018-2023)
6.1.3 Europe Hirudin Sales in Value by Country (2018-2023)
6.2 Europe Hirudin Forecasted Market Size by Country
6.2.1 Europe Hirudin Sales in Volume by Country (2024-2029)
6.2.2 Europe Hirudin Sales in Value by Country (2024-2029)
7 Asia-Pacific Hirudin by Region
7.1 Asia-Pacific Hirudin Historic Market Size by Region
7.1.1 Asia-Pacific Hirudin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hirudin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hirudin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hirudin Forecasted Market Size by Region
7.2.1 Asia-Pacific Hirudin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hirudin Sales in Value by Region (2024-2029)
8 Latin America Hirudin by Country
8.1 Latin America Hirudin Historic Market Size by Country
8.1.1 Latin America Hirudin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hirudin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hirudin Sales in Value by Country (2018-2023)
8.2 Latin America Hirudin Forecasted Market Size by Country
8.2.1 Latin America Hirudin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hirudin Sales in Value by Country (2024-2029)
9 Middle East and Africa Hirudin by Country
9.1 Middle East and Africa Hirudin Historic Market Size by Country
9.1.1 Middle East and Africa Hirudin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hirudin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hirudin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hirudin Forecasted Market Size by Country
9.2.1 Middle East and Africa Hirudin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hirudin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 The Medicines Company
10.1.1 The Medicines Company Company Information
10.1.2 The Medicines Company Introduction and Business Overview
10.1.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 The Medicines Company Hirudin Products Offered
10.1.5 The Medicines Company Recent Development
10.2 Keyken
10.2.1 Keyken Company Information
10.2.2 Keyken Introduction and Business Overview
10.2.3 Keyken Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Keyken Hirudin Products Offered
10.2.5 Keyken Recent Development
10.3 Minapharm
10.3.1 Minapharm Company Information
10.3.2 Minapharm Introduction and Business Overview
10.3.3 Minapharm Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Minapharm Hirudin Products Offered
10.3.5 Minapharm Recent Development
10.4 Abbott
10.4.1 Abbott Company Information
10.4.2 Abbott Introduction and Business Overview
10.4.3 Abbott Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abbott Hirudin Products Offered
10.4.5 Abbott Recent Development
10.5 SALUBRIS
10.5.1 SALUBRIS Company Information
10.5.2 SALUBRIS Introduction and Business Overview
10.5.3 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SALUBRIS Hirudin Products Offered
10.5.5 SALUBRIS Recent Development
10.6 Pfizer, Inc
10.6.1 Pfizer, Inc Company Information
10.6.2 Pfizer, Inc Introduction and Business Overview
10.6.3 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer, Inc Hirudin Products Offered
10.6.5 Pfizer, Inc Recent Development
10.7 Teva Pharmaceutical Industries Ltd
10.7.1 Teva Pharmaceutical Industries Ltd Company Information
10.7.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Pharmaceutical Industries Ltd Hirudin Products Offered
10.7.5 Teva Pharmaceutical Industries Ltd Recent Development
10.8 DUOPUTAI
10.8.1 DUOPUTAI Company Information
10.8.2 DUOPUTAI Introduction and Business Overview
10.8.3 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 DUOPUTAI Hirudin Products Offered
10.8.5 DUOPUTAI Recent Development
10.9 Pentapharm
10.9.1 Pentapharm Company Information
10.9.2 Pentapharm Introduction and Business Overview
10.9.3 Pentapharm Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pentapharm Hirudin Products Offered
10.9.5 Pentapharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hirudin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hirudin Industrial Chain Analysis
11.4 Hirudin Market Dynamics
11.4.1 Hirudin Industry Trends
11.4.2 Hirudin Market Drivers
11.4.3 Hirudin Market Challenges
11.4.4 Hirudin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hirudin Distributors
12.3 Hirudin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
